Evidence map›Paper›PMID 32377561›Full record

ArticleAdvanced therapeutics2019

Composite thermoresponsive hydrogel with auranofin-loaded nanoparticles for topical treatment of vaginal trichomonad infection.

Yue Zhang, Yukiko Miyamoto, Sozaburo Ihara, Justin Z Yang, Douglas E Zuill, Pavimol Angsantikul, Qiangzhe Zhang, Weiwei Gao, Liangfang Zhang, Lars Eckmann

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced therapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Yue ZhangDepartment of NanoEngineering and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.
Yukiko MiyamotoDepartment of Medicine, University of California San Diego, La Jolla, California 92093, USA.
Sozaburo IharaDepartment of Medicine, University of California San Diego, La Jolla, California 92093, USA.
Justin Z YangDepartment of Medicine, University of California San Diego, La Jolla, California 92093, USA.
Douglas E ZuillDepartment of Medicine, University of California San Diego, La Jolla, California 92093, USA.
Pavimol AngsantikulDepartment of NanoEngineering and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.
Qiangzhe ZhangDepartment of NanoEngineering and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.
Weiwei GaoDepartment of NanoEngineering and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.
Liangfang ZhangDepartment of NanoEngineering and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.
Lars EckmannDepartment of Medicine, University of California San Diego, La Jolla, California 92093, USA.
University of California San Diego · US

Funding

San Diego Digestive Diseases Research CenterP30DK120515 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Bernd G. Schnabl · 2019 to 2026
$10.8M
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma MetastasisR01CA200574 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LI, SHULIN, ZHANG, LIANGFANG · 2016 to 2020
$1.8M
Selective proteasome inhibitors for trichomoniasisR21AI146387 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ECKMANN, LARS, O'DONOGHUE, ANTHONY JOHN · 2019 to 2020
$433k
NCI NIH HHS R01 CA200574NIAID NIH HHS R21 AI146387NIDDK NIH HHS P30 DK120515
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobialdrug deliveryhydrogelnanoparticleTrichomoniasis

Identifiers

PMID32377561
PMCPMC7202563
OpenAlexW2982344625

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.